Добірка наукової літератури з теми "Maytansinoids"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Maytansinoids".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Maytansinoids"
Giles, Francis, Rodica Morariu-Zamfir, John Lambert, Srdan Verstovsek, Deborah Thomas, Farhad Ravandi, and Dan Deangelo. "Phase I Study of AVE9633, an AntiCD33-Maytansinoid Immunoconjugate, Administered as an Intravenous Infusion in Patients with Refractory/Relapsed CD33-Positive Acute Myeloid Leukemia (AML)." Blood 108, no. 11 (November 16, 2006): 4548. http://dx.doi.org/10.1182/blood.v108.11.4548.4548.
Повний текст джерелаPlattner, Ronald D., and Richard G. Powell. "Tandem Mass Spectrometry of Maytansinoids." Journal of Natural Products 49, no. 3 (May 1986): 475–82. http://dx.doi.org/10.1021/np50045a016.
Повний текст джерелаLarson, Gretchen M., Brian T. Schaneberg, and Albert T. Sneden. "Two New Maytansinoids fromMaytenus buchananii." Journal of Natural Products 62, no. 2 (February 1999): 361–63. http://dx.doi.org/10.1021/np9803732.
Повний текст джерелаLo, Chen-Fu, Tai-Yu Chiu, Yu-Tzu Liu, Li-Rung Huang, Teng-Kuang Yeh, Kuan-Hsun Huang, Kuan-Liang Liu, et al. "Synthesis and Evaluation of Small Molecule Drug Conjugates Harnessing Thioester-Linked Maytansinoids." Pharmaceutics 14, no. 7 (June 21, 2022): 1316. http://dx.doi.org/10.3390/pharmaceutics14071316.
Повний текст джерелаNittoli, Thomas, Frank Delfino, Marcus Kelly, Serena Carosso, Thomas Markotan, Arthur Kunz, Zhaoyuan Chen, et al. "Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids." Bioorganic & Medicinal Chemistry 28, no. 23 (December 2020): 115785. http://dx.doi.org/10.1016/j.bmc.2020.115785.
Повний текст джерелаSuchocki, John A., and Albert T. Sneden. "New maytansinoids: reduction products of the C(9)-carbinolamide." Journal of Organic Chemistry 53, no. 17 (August 1988): 4116–18. http://dx.doi.org/10.1021/jo00252a047.
Повний текст джерелаLadino, Cynthia A., Ravi V. J. Chari, Lizabeth A. Bourret, Nancy L. Kedersha, and Victor S. Goldmacher. "Folate-maytansinoids: Target-selective drugs of low molecular weight." International Journal of Cancer 73, no. 6 (December 10, 1997): 859–64. http://dx.doi.org/10.1002/(sici)1097-0215(19971210)73:6<859::aid-ijc16>3.0.co;2-#.
Повний текст джерелаPerrino, Elena, Martina Steiner, Nikolaus Krall, Gonçalo J. L. Bernardes, Francesca Pretto, Giulio Casi, and Dario Neri. "Curative Properties of Noninternalizing Antibody–Drug Conjugates Based on Maytansinoids." Cancer Research 74, no. 9 (February 11, 2014): 2569–78. http://dx.doi.org/10.1158/0008-5472.can-13-2990.
Повний текст джерелаNittoli, Thomas, Marcus P. Kelly, Frank Delfino, John Rudge, Arthur Kunz, Thomas Markotan, Jan Spink, et al. "Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids." Bioorganic & Medicinal Chemistry 26, no. 9 (May 2018): 2271–79. http://dx.doi.org/10.1016/j.bmc.2018.02.025.
Повний текст джерелаLiu, C., B. M. Tadayoni, L. A. Bourret, K. M. Mattocks, S. M. Derr, W. C. Widdison, N. L. Kedersha, et al. "Eradication of large colon tumor xenografts by targeted delivery of maytansinoids." Proceedings of the National Academy of Sciences 93, no. 16 (August 6, 1996): 8618–23. http://dx.doi.org/10.1073/pnas.93.16.8618.
Повний текст джерелаДисертації з теми "Maytansinoids"
Hodgson, D. M. "Synthetic studies towards the maytansinoids." Thesis, University of Southampton, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.330146.
Повний текст джерелаPrinciotto, S. "Synthesis of intermediates for the preparation of Active Pharmaceutical Ingredients (APIs)." Doctoral thesis, Università di Siena, 2020. http://hdl.handle.net/11365/1095607.
Повний текст джерелаInositols are a class of 9 compounds characterized by the presence of the cyclohexan-hex-ol moiety, with different stereochemical configuration of the carbons present upon the structure. In particular, myo-inositol is widely present in nature (plants and mammals), mostly in form of phytate (as phosphorus reservoir within the plants) and as important components of cellular membrane (phosphatidyl inositol phosphates) or second messengers of intracellular signaling cascades (inositol triphosphate, IP3). Due to its very important role within different physiological conditions, in the second section of this thesis the performed reactivity studies about myo-inositol were described. In particular, the different regio- and stereoselectivities in presence of different reaction conditions were reported. Different protection protocols for the myo-inositol orthoformate were established and the results were rationalized and applied for the total synthesis of a natural origin compound, with particular attention to the desymmetrization process, necessary for the obtainment of optically pure derivatives.
Meurer, Kristina. "Untersuchungen zum Vorkommen von Maytansinoiden in Höheren Pflanzen : ein Beitrag zur Suche nach einem maytansinproduzierenden Mikroorganismus /." [S.l. : s.n.], 2002. http://www.gbv.de/dms/bs/toc/356980243.pdf.
Повний текст джерелаBrünjes, Marco. "Studien zur chemoenzymatischen Synthese und Biosynthese von Maytansinoid-Analoga." [S.l.] : [s.n.], 2006. http://deposit.ddb.de/cgi-bin/dokserv?idn=98052542X.
Повний текст джерелаFrenzel, Thomas. "Studien zur chemoenzymatischen Synthese von Maytansinoid-Analoga Synthese von seco-Proansamitocin /." [S.l.] : [s.n.], 2005. http://deposit.ddb.de/cgi-bin/dokserv?idn=977228118.
Повний текст джерелаBrünjes, Marco [Verfasser]. "Studien zur chemoenzymatischen Synthese und Biosynthese von Maytansinoid-Analoga / von Marco Brünjes." 2006. http://d-nb.info/98052542X/34.
Повний текст джерелаMERLINO, GIUSEPPE. "Characterization of MEN1309/OBT076, a new antibody conjugated to the DM4 maytansinoide toxin." Doctoral thesis, 2020. http://hdl.handle.net/11573/1341225.
Повний текст джерелаFrenzel, Thomas [Verfasser]. "Studien zur chemoenzymatischen Synthese von Maytansinoid-Analoga : Synthese von seco-Proansamitocin / von Thomas Frenzel." 2005. http://d-nb.info/977228118/34.
Повний текст джерелаЧастини книг з теми "Maytansinoids"
Erickson, Hans. "Antibody-Maytansinoid Conjugates: From the Bench to the Clinic." In Drug Delivery in Oncology, 375–94. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2011. http://dx.doi.org/10.1002/9783527634057.ch13.
Повний текст джерелаWiddison, Wayne C. "CHAPTER 5. Maytansinoid Payloads for Antibody–Drug Conjugates (ADCs)." In Cytotoxic Payloads for Antibody–Drug Conjugates, 100–116. Cambridge: Royal Society of Chemistry, 2019. http://dx.doi.org/10.1039/9781788012898-00100.
Повний текст джерелаLambert, John M., Veronique Blanc, Nathalie Le Bail, and Anne Bousseau. "Targeting CD19 with SAR3419, an anti-CD19-Maytansinoid Conjugate for the Treatment of B Cell Malignancies." In Antibody-Drug Conjugates and Immunotoxins, 149–60. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5456-4_9.
Повний текст джерела"Maytansinoids." In Encyclopedia of Genetics, Genomics, Proteomics and Informatics, 1166. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_9986.
Повний текст джерела"Ansamitocins (Maytansinoids)." In Anticancer Agents from Natural Products, 423–44. CRC Press, 2011. http://dx.doi.org/10.1201/b11185-21.
Повний текст джерела"Ansamitocins (Maytansinoids)." In Anticancer Agents from Natural Products, 337–54. CRC Press, 2005. http://dx.doi.org/10.1201/9781420039658-21.
Повний текст джерелаТези доповідей конференцій з теми "Maytansinoids"
Sala, Gianluca, Emily Capone, Enza Piccolo, Sara Ponziani, Roberta Gentile, Rodolfo Ippoliti, Francesco Giansanti, and Stefano Iacobelli. "Abstract 748: Non-internalizing site-specific antibody-drug conjugates based on maytansinoids display curative properties." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-748.
Повний текст джерелаNollmann, Friederike I., Patricia Perez Galan, Javier Garcia Fernandez, Heidi K. Walter, Johannes P. Magnusson, Federico Medda, Felix Kratz, et al. "Abstract 1657: Structure-activity relationship studies and biological evaluation of novel maytansinoids, a class of highly selective tubulin inhibitors." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-1657.
Повний текст джерелаNollmann, Friederike I., Patricia Perez Galan, Javier Garcia Fernandez, Heidi K. Walter, Johannes P. Magnusson, Federico Medda, Felix Kratz, et al. "Abstract 2661: Novel albumin-binding maytansinoids inducing long-term partial and complete tumor regressions in several human cancer xenograft models in nude mice." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-2661.
Повний текст джерелаWhiteman, Kathleen R., Holly A. Johnson, Xiuxia Sun, Robert Mastico, Susan Emrich, Lauren Clancy, Hans Erickson, and Jan Pinkas. "Abstract 4628: Anti-tumor activity and pharmacokinetics of the anti-FOLR1-maytansinoid conjugate IMGN853 is maintained over a wide range of maytansinoid-to-antibody ratios." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4628.
Повний текст джерелаWiddison, Wayne C., Sharon Wilhelm, Karen Veale, Yelena Kovtun, Hans Erickson, Charlene Audette, Barbara Leeca, Gregory Jones, and Ravi Chari. "Abstract 2668: Detoxification of metabolites from antibody-maytansinoid conjugates by human liver microsomes." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2668.
Повний текст джерелаSun, Xiuxia, Jose F. Ponte, Nicholas C. Yoder, Jennifer Coccia, Leanne Lanieri, Rassol Laleau, Qifeng Qiu, et al. "Abstract 4531: Effects of drug load on therapeutic index for antibody-maytansinoid conjugates." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4531.
Повний текст джерелаKellogg, Brenda, Charlene Audette, Hans Erickson, Michelle Mayo, Michael Okamoto, Jan Pinkas, Xiuxia Sun, et al. "Abstract 4404: Comparativein vivopharmacokinetic properties of antibody-maytansinoid conjugates with alternative non-cleavable linkers." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-4404.
Повний текст джерелаSingh, Rajeeva, Nathan Fishkin, Yelena Kovtun, Gregory Jones, Jose Ponte, Hans Erickson, Erica Hong, et al. "Abstract C164: New tri-glycyl peptide linker offers advantages for maytansinoid antibody-drug conjugates (ADCs)." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-c164.
Повний текст джерелаAb, Olga, Laura M. Bartle, Lingyun Rui, Jennifer Coccia, Holly A. Johnson, Kathleen R. Whiteman, Brenda Kellogg, Lauren Clancy, Xiuxia Sun, and Victor S. Goldmacher. "Abstract 4576: IMGN853, an anti-Folate Receptor I antibody-maytansinoid conjugate for targeted cancer therapy." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4576.
Повний текст джерелаWiddison, Wayne C., Joe Ponte, Jennifer Coccia, Yulius Setiady, Ling Dong, Anja Skaletskaya, Nathan Fishkin, et al. "Abstract 1618: New peptide-linked anilino-maytansinoid antibody-drug conjugates (ADCs) for the treatment of cancer." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1618.
Повний текст джерела